KELLY SMEESTER: Open Payments
NPI 1952601759 · LONE TREE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,404 in 167 payments from 19 companies in 2025. Trend: 2023 $2,094 · 2024 $3,740 · 2025 $5,404
Food & beverage: $4,067Consulting: $1,080Education: $257
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $1,927 |
| ABBVIE INC. | 44 | $962 |
| Novo Nordisk Inc | 10 | $393 |
| Madrigal Pharmaceuticals | 5 | $340 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $286 |
| Lilly USA, LLC | 9 | $208 |
| GENZYME CORPORATION | 8 | $203 |
| QOL Medical, LLC | 15 | $198 |
| PFIZER INC. | 11 | $163 |
| Mirum Pharmaceuticals, Inc. | 1 | $145 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, SKYRIZI, DUPIXENT, ENTYVIO, OMVOH, Sucraid.
Industry payments across CO — which companies pay providers there.
